Power Law company profile

ARMO Bio Sciences

Biotech & Life Sciences · Palo Alto, United States · Founded 2013 · IPO 2018 Unicorn

A biotechnology company that develops immune modulatory biologic therapeutics

Valuation

$1.60B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

12 investors on ARMO Bio Sciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

OrbiMed

DAG Ventures

Kleiner Perkins

Series B+ 9 investors entered at this stage

Sequoia

RTW Investments

Qiming Venture Partners USA

Celgene

+ND Capital

Qiming Venture Partners

Quan Capital

Industrial Investors Group

Decheng Capital

Global footprint

Where ARMO Bio Sciences has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Patent intelligence

$11M patent portfolio · 9 active families

Estimated portfolio value

$11M

0.67% of market cap · 20.8× smaller than top peer Ganymed Pharmaceuticals ($223M)

9 active patent families

Where ARMO Bio Sciences innovates DiseaseInterleukinWhite blood cellDisease injuryInterleukin 10

Where ARMO Bio Sciences concentrates vs peers

Each axis is a top-10 topic across ARMO Bio Sciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about ARMO Bio Sciences

An AI-synthesized read of the highest-engagement posts about ARMO Bio Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ARMO Bio Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles